An efficient route to the synthesis of dibenzylbutanediol lignans and their analogues was reported. The syntheses were based on a strategy involving Stobbe condensation and alkylation reaction to give the skeleton of lignan, the resolution of (±)-diacid with quinine, the transformation of functional groups to obtain seven dibenzylbutanediol lignans and one analogue. Among the synthesized lignans, four compounds were natural products. All dibenzylbutanediol lignans and their analogue synthesized were evaluated on HIV Tat transactivation in human epithelial cells, HSV-1 gene and human leukemic, liver, prostate, stomach, and breast cancer cell in vitro, but some compounds displayed weak activity against HIV, HSV and MDA-MB-435 human breast cancer cell.
INTRODUCTION
Lignans are a class of secondary plant metabolites produced by oxidative dimerization of two phenylpropanoid units. They are widely distributed in the plant kingdom and have been found in species belonging to more than seventy families. Lignans are found in roots, rhizomes, stems, leaves, seeds and fruits 1, 2 . Lignans probably participate in plant development, and may play an important role in plant defense against various biological pathogens and pests. In addition to their purpose in nature, lignans also possess significant pharmacological activities, including antitumor, anti-inflammatory, immunosuppressive, cardiovascular, antioxidant and antiviral actions. From a chemical point of view, lignans show an enormous structural diversity, although their molecular backbone consists only of two phenylpropane units. Different families of lignans include the aryltetrahydronaphthalenes, typified by podophyllotoxin, the diverse family of dibenzocyclooctadienes, the dibenzylbutanediol lignans and so on [3] [4] [5] [6] . Dibenzylbutanediol lignans and their analogues are a class of lignans that have received considerable interest because of their biological and medicinal properties. The dibenzylbutanediol lignans seco-isolariciresinol and its metabolits enterodiol induced a significant decrease in the invasion (MDAMB-231) through Matrigel 7 .Isotaxiresinol and its analogue (+)-taxiresinol from Taxus wallichiana were explored for anticancer properties. It was found that two lignans were active against colon adenocarcinoma cell lines in the MTT assay. However, isotaxiresinol was most active against the Caco-2 cell line in a clonogenic assay 8 . Kuepeli et al. investigated five dibenzylbutanediol lignans and the analogues for their anti-inflammatory activities, in which the lignans significantly inhibited carrageenan-induced hind paw edema in mice. The result showed that lariciresinol and isolariciresinol possess a potent in vitro inhibitory effect on the production of TNF-α, a pro-inflammatory cytokine 9 . Other many dibenzylbutanediol lignans and their analogues have been shown to have a beneficial anti-virus effect 10 . These studies help to conclude that in future the dibenzylbutanediol lignans and their analogues may be an effective means of dealing with cancer, as well as providing antiviral and anti-inflammatory benefits.
Several strategies for the synthesis of dibenzylbutanediol lignans and their analogues have been reported [11] [12] [13] [14] [15] .Among them, the alkylation of β-substituted γ-butyrolactone with an appropriate benzylic halide is the most widely used 16 . Herein, we report an efficient route to the synthesis of dibenzylbutanediol lignans and their analogues. The syntheses were based on a strategy involving Stobbe condensation and alkylation reaction to give the skeleton of lignan, the transformation of functional groups to obtain target compound. All lignans synthesized were evaluated on HIV Tat transactivation in human epithelial cells, HSV-1 gene and human leukemic, liver, prostate, stomach, and breast cancer cell in vitro. We would like to point out structure-activity relationship could be established, and the mechanism of action was determined.
EXPERIMENTAL
Melting points were taken on Gallenkamp melting point apparatus and are uncorrected. Optical rotations were determined on a Perkin-Elmer 341 polarimeter. Infrared spectra were recorded on a Nicolet NEXUS 670 FT−IR.
The
1 HNMR and 13 CNMR spectra were recorded on Mercury Plus−300 MHz and Avance-200 MHz spectrometers. Mass spectra were recorded on a ZAB−HS spectrometer. HRMS were obtained on a Bruker Daltonics APEXII47e spectrometer. Flash column chromatography was performed on silica gel (200-300 mesh) and TLC inspections on silica gel GF 254 plates.
Diethyl 2-(3',4'-methylenedioxybenzylidene)succinate 2a. The piperonal 1a (15.0 g, 100 mmol) and diethylsuccinate (17.4 g, 100 mmol) were added to a solution of NaOEt (13.6 g, 200 mmol) in EtOH (200 ml). After refluxing for 4 hrs, ethanol was removed. The residue was cooled and acidified with HCl (5N). The mixture was extracted with EtOAc (3×80 ml). The EtOAc layer was then re-extracted with NaHCO 3 saturated solution (100 ml). The NaHCO 3 extract was acidificated with HCl and the pH value was adjusted to 2. Then the obtained an oily layer was again extracted with EtOAc (3×100 ml). The combined organic layer was dried over MgSO 4 and concentrated in vacuo. This residue was then added to the mixture of EtOH (250 ml), benzene (100 ml), and H 2 SO 4 (2 ml), then refluxed in a Dean and Stark apparatus for 24 hrs so that water removed. The reaction mixture was concentrated in vacuo and extracted with EtOAc (200 ml), then washed with the NaHCO 3 saturated solution (3×50 ml). The extract was dried over MgSO 4 To a well-stirred solution of compound 2a (24.5 g, 80 mmol) in THF (100 ml) was added dropwise a solution of LDA (80 mmol, 2 M in THF) in THF at -78°C under nitrogen atmosphere. The mixture was stirred at this temperature for 20 mins, then 3,4-methylenedioxybenzyl bromide (17.2 g, 80 mmol) in THF (50 ml) was added. The mixture was stirred at -78°C for 2 hrs. The mixture was quenched with NH 4 Cl saturated solution (100 ml). After warmed to room temperature, the mixture was extracted with CH 2 Cl 2 (3 × 80 ml) and the organic layer was dried over MgSO 4 and concentrated in vacuo. Flash chromatography of the residue over silica gel gave compound 3a as a white crystal (31.6 g, 90% (-)-2-(3',4'-methylenedioxybenzylidene)-3-(3'',4''-methylenedioxybenzyl)succinic acid 4a. Diester 3a (26.4 g, 60 mmol) was added to a solution of 20% aqueous NaOH (250 ml) and refluxed for 3 hrs. After cooled to room temperature, the mixture was washed with EtOAc (3×30 ml). After decolored with active carbon, the mixture was acidificated with HCl (2N), and obtained white solids. The crude product was crystallized from HOAc to give the (±)-diacid 4a. The (±)-diacid 4a and (-)-quinine (38.9 g, 120 mmol) in ethanol (120 ml) was refluxed for 1 hrs. The reaction mixture was allowed to cool to room temperature slowly, fine white crystals were obtained. Two recrystallizations from ethanol was added to a solution of HCl (2 N, 100 ml) and stirred for 1hrs. The mixture was extracted with EtOAc (3 × 80 ml), and the extract was dried over MgSO 4 and evaporated. The white solids were recrystallized in EtOAc to yield the (-)-diacid 4a as a white crystal (10.1 g, 44% (-)-Diethyl 2-(3',4'-methylenedioxybenzylidene)-3-(3'',4''-methylenedioxybenzyl)succinate 5a. To the 151 ml mixture of EtOH : benzene : H 2 SO 4 (100 : 50 : 1) was added 4a (7.7 g, 20 mmol), refluxed in a Dean and Stark apparatus for 36 hrs so that water removed. The reaction mixture was concentrated in vacuo and extracted with EtOAc (100 ml), and then neutralized with the NaHCO 3 saturated solution (3×30 ml). The extract was dried over MgSO 4 and concentrated in vacuo. Flash column chromatography of the residue gave (-)-diester 5a as a colorless oil (8.0 g, 91%). 3 g) and 8b (1.45 g) were obtained. (-)-Dihydro-3',4'-dimethoxy-3'',4''-demethylenedioxycubebin (7b) C-1), 60.3 (C-4) , 100.7 (OCH 2 O), 108.0 (C-5'), 109.3 (C-5''), 111.2 (C-2'), 112.1 (C-2''), 121.0 (C-6'), 121.8 (C-6''), 133.1 (C-1'), 134.3 (C-1'' 
RESULTS AND DISCUSSION

Synthesis of compounds
Piperonal 1a or veratraldehyde 1b was reacted with diethyl succinate in sodium ethoxide-ethanol solution to produce the benzylidene succinate halfester, following by the esterification provided the diester 2a or 2b. Alkylation reaction of 2a or 2b to diester 3a or 3b was achieved by treatment with LDA and 3, 4-methylenedioxybenzyl bromide under -78°C. Hydrolysis of diester 3a or 3b under conventional conditions (NaOH, H 2 O) produced diacid, following by resolution via the quinine salt afforded diacid (-)-4a or (-)-4b, (+)-4a' or (+)-4b'. The diacid (-)-4a or (-)-4b was esterified to produce unsaturated diester (-)-5a or (-)-5b (Scheme 1).
Scheme 1 Synthesis of compounds 5a, 5b
Reaction of (-)-5a or (-)-5b with LiAlH 4 /AlCl 3 in THF afforded unsaturated diol lignans (-)-6a or (-)-6b (Scheme 2).
Scheme 2 Synthesis of compounds 6a, 6b
Treatment of (-)-5a or (-)-5b with Pd/C (10%) under hydrogen atmosphere gave saturated diester, following by reduction with LiAlH 4 in THF to produce a readily separable mixture (approximate 1:1) of dibenzylbutanediol lignans threo-(-)-7a and erythro-8a or threo-(-)-7b and erythro-8b (Scheme 3). erythro-7a did not have optical rotation and was a meso-compound. The spectral data threo-(-)-7a, erythro-8a and threo-(-)-7b were in agreement with those found in the literatures.
Scheme 3 Synthesis of compounds 7a, 7b, 8a, 8b
When (-)-5a was treated with DDQ in acetic acid dehydrogenation occurred to give the compound 9. Treatment of (-)-5a with DDQ in trifluoroacetic acid dehydrogenation afforded the dibenzocyclooctadiene diol 10 (Scheme 4).
Scheme 4 Synthesis of compounds 9, 10
Bioactivity Anti-virus activity The synthesized compounds 6a, 6b, 7a, 7b, 8a, 8b, 9 and 10 were evaluated for their antiviral activities against HIV-1 and HSV in vitro. The anti-HIV assays of the synthesized lignans reported here were in agree with the methods previously reported 22 . Among all the synthesized compounds, derivatives 7a, 7b, 8a, 8b with two free hydroxyl group were the most potent inhibitors of HIV replication, coupled with the highest selectivity index. In fact, compound erythro-8b showed the weak activities against HIV-1 (IC 50 =150 µg/ml), while the rest of the compounds did not exhibit any obvious activity.
The process of anti-HSV assay was previously described 23 . The results showed that 8b exhibited antiviral activity against herpes virus (77.04 µg/ml). The rest of the compounds did not exhibit any obvious activity. On the other hand, the results showed that SI of 8b was much lower (SI<1.0). Thus, we should enhance SI in the latter study in structure-function relationship in order to increase the selectivity of activity.
The biological data of the synthesized compounds led to some considerations that permitted a more regular pattern. Only compound 8b, bearing two free hydroxyl groups with erythro-structure, was characterized by modest antiviral activity against both HIV-1 and HSV. Thus, within the dibenzylbutanediol lignans, the best activity was provided by the two free hydroxyl groups and erythro-structure.
Anti-tumor activity
The synthesized dibenzylbutanediol lignans and their analogues were evaluated against HL-60 human leukemic cell, PC-3MIE8 human prostatic carcinoma cell, BGC-823 human stomach cancer cell, MDA-MB-435 human breast cancer cell in vitro, and the assays of the lignans have been previously published 24 . We observed that all of the compounds at 10 M and 10 -7 M inhibited HL-60 cell, PC-3MIE8 cell, BGC-823 cell, Bel-7402 cell and MDA-MB-435 cell. Most interesting activities, however, were showed against MDA-MB-435 human breast cancer cell. In a screen against MDA-MB-435 human breast cancer cell, we observed that the compound 10 possessed weak activity and showed inhibition ratio above 22.3% at 10 -5
M. The anti-tumor activities of the other compounds indicated the inhibitory rates of tumor cell were less than 20% or showed no obvious anti-tumor activity.
The biological activity of the synthesized compounds showed the dibenzylbutanediol lignans exhibited low inhibition ratio against tumor cell. Among these serial modifications, only diol-10 with dibenzocyclooctadiene structure gave the weak activity against human breast cancer cell. Thus, dibenzocyclooctadiene structure seems to be beneficial to inhibit breast cancer cell and led to an increase in anti-tumor activity.
CONCLUSIONS
In the aspect of synthesis of compounds, we have developed an efficient chiral synthetic route to give eight dibenzylbutanediol lignans including four natural products. With cheap materials, short experimental procedures, mild conditions and simple operations, the route exhibited more potential value in the future. Within the dibenzylbutanediol lignans, lignan 8b with the two free hydroxyl groups and erythro-structure showed the best anti-virus activity. In the aspect of anti-tumor activity, lignan 10 with dibenzocyclooctadiene structure seem to be beneficial to inhibit breast cancer cell and dibenzocyclooctadiene ring led to an increase in anti-tumor activity.
